Report Detail

Request for Sample of this report

Other COVID-19 Impact on Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Size, Status and Forecast 2020-2026

  • RnM4074732
    • |
  • 23 June, 2020
    • |
  • Global
    • |
  • 128 Pages
    • |
  • QYResearch
    • |
  • Other

This report focuses on the global Squamous Non-Small Cell Lung Cancer Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Squamous Non-Small Cell Lung Cancer Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study
Ascenta Therapeutics, Inc.
AstraZeneca Plc
AVEO Pharmaceuticals, Inc.
Bayer AG
BIND Therapeutics, Inc.
Boehringer Ingelheim GmbH
Bristol-Myers Squibb Company
Eli Lilly and Company
F. Hoffmann-La Roche Ltd.
Five Prime Therapeutics, Inc.
Genentech, Inc.
Incyte Corporation
Johnson & Johnson
MacroGenics, Inc.
Novartis AG
Oncogenex Pharmaceuticals, Inc.
PsiOxus Therapeutics Limited

Market segment by Type, the product can be split into
BMS-906024
Buparlisib Hydrochloride
FP-1039
Ipilimumab
JNJ-42756493
Lenvatinib
Others
Market segment by Application, split into
Research Center
Hospital
Clinic

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Squamous Non-Small Cell Lung Cancer Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the Squamous Non-Small Cell Lung Cancer Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Squamous Non-Small Cell Lung Cancer Therapeutics are as follows:
History Year: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by Squamous Non-Small Cell Lung Cancer Therapeutics Revenue
  • 1.4 Market Analysis by Type
    • 1.4.1 Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 BMS-906024
    • 1.4.3 Buparlisib Hydrochloride
    • 1.4.4 FP-1039
    • 1.4.5 Ipilimumab
    • 1.4.6 JNJ-42756493
    • 1.4.7 Lenvatinib
    • 1.4.8 Others
  • 1.5 Market by Application
    • 1.5.1 Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Share by Application: 2020 VS 2026
    • 1.5.2 Research Center
    • 1.5.3 Hospital
    • 1.5.4 Clinic
  • 1.6 Coronavirus Disease 2019 (Covid-19): Squamous Non-Small Cell Lung Cancer Therapeutics Industry Impact
    • 1.6.1 How the Covid-19 is Affecting the Squamous Non-Small Cell Lung Cancer Therapeutics Industry
      • 1.6.1.1 Squamous Non-Small Cell Lung Cancer Therapeutics Business Impact Assessment - Covid-19
      • 1.6.1.2 Supply Chain Challenges
      • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
    • 1.6.2 Market Trends and Squamous Non-Small Cell Lung Cancer Therapeutics Potential Opportunities in the COVID-19 Landscape
    • 1.6.3 Measures / Proposal against Covid-19
      • 1.6.3.1 Government Measures to Combat Covid-19 Impact
      • 1.6.3.2 Proposal for Squamous Non-Small Cell Lung Cancer Therapeutics Players to Combat Covid-19 Impact
  • 1.7 Study Objectives
  • 1.8 Years Considered

2 Global Growth Trends by Regions

  • 2.1 Squamous Non-Small Cell Lung Cancer Therapeutics Market Perspective (2015-2026)
  • 2.2 Squamous Non-Small Cell Lung Cancer Therapeutics Growth Trends by Regions
    • 2.2.1 Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Squamous Non-Small Cell Lung Cancer Therapeutics Historic Market Share by Regions (2015-2020)
    • 2.2.3 Squamous Non-Small Cell Lung Cancer Therapeutics Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 Squamous Non-Small Cell Lung Cancer Therapeutics Market Growth Strategy
    • 2.3.6 Primary Interviews with Key Squamous Non-Small Cell Lung Cancer Therapeutics Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top Squamous Non-Small Cell Lung Cancer Therapeutics Players by Market Size
    • 3.1.1 Global Top Squamous Non-Small Cell Lung Cancer Therapeutics Players by Revenue (2015-2020)
    • 3.1.2 Global Squamous Non-Small Cell Lung Cancer Therapeutics Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Concentration Ratio
    • 3.2.1 Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by Squamous Non-Small Cell Lung Cancer Therapeutics Revenue in 2019
  • 3.3 Squamous Non-Small Cell Lung Cancer Therapeutics Key Players Head office and Area Served
  • 3.4 Key Players Squamous Non-Small Cell Lung Cancer Therapeutics Product Solution and Service
  • 3.5 Date of Enter into Squamous Non-Small Cell Lung Cancer Therapeutics Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

  • 4.1 Global Squamous Non-Small Cell Lung Cancer Therapeutics Historic Market Size by Type (2015-2020)
  • 4.2 Global Squamous Non-Small Cell Lung Cancer Therapeutics Forecasted Market Size by Type (2021-2026)

5 Squamous Non-Small Cell Lung Cancer Therapeutics Breakdown Data by Application (2015-2026)

  • 5.1 Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2015-2020)
  • 5.2 Global Squamous Non-Small Cell Lung Cancer Therapeutics Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size (2015-2020)
  • 6.2 Squamous Non-Small Cell Lung Cancer Therapeutics Key Players in North America (2019-2020)
  • 6.3 North America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2015-2020)
  • 6.4 North America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe Squamous Non-Small Cell Lung Cancer Therapeutics Market Size (2015-2020)
  • 7.2 Squamous Non-Small Cell Lung Cancer Therapeutics Key Players in Europe (2019-2020)
  • 7.3 Europe Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2015-2020)
  • 7.4 Europe Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2015-2020)

8 China

  • 8.1 China Squamous Non-Small Cell Lung Cancer Therapeutics Market Size (2015-2020)
  • 8.2 Squamous Non-Small Cell Lung Cancer Therapeutics Key Players in China (2019-2020)
  • 8.3 China Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2015-2020)
  • 8.4 China Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan Squamous Non-Small Cell Lung Cancer Therapeutics Market Size (2015-2020)
  • 9.2 Squamous Non-Small Cell Lung Cancer Therapeutics Key Players in Japan (2019-2020)
  • 9.3 Japan Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2015-2020)
  • 9.4 Japan Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2015-2020)

10 Southeast Asia

  • 10.1 Southeast Asia Squamous Non-Small Cell Lung Cancer Therapeutics Market Size (2015-2020)
  • 10.2 Squamous Non-Small Cell Lung Cancer Therapeutics Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2015-2020)
  • 10.4 Southeast Asia Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2015-2020)

11 India

  • 11.1 India Squamous Non-Small Cell Lung Cancer Therapeutics Market Size (2015-2020)
  • 11.2 Squamous Non-Small Cell Lung Cancer Therapeutics Key Players in India (2019-2020)
  • 11.3 India Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2015-2020)
  • 11.4 India Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2015-2020)

12 Central & South America

  • 12.1 Central & South America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size (2015-2020)
  • 12.2 Squamous Non-Small Cell Lung Cancer Therapeutics Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2015-2020)
  • 12.4 Central & South America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2015-2020)

13 Key Players Profiles

  • 13.1 Ascenta Therapeutics, Inc.
    • 13.1.1 Ascenta Therapeutics, Inc. Company Details
    • 13.1.2 Ascenta Therapeutics, Inc. Business Overview and Its Total Revenue
    • 13.1.3 Ascenta Therapeutics, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Introduction
    • 13.1.4 Ascenta Therapeutics, Inc. Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2015-2020))
    • 13.1.5 Ascenta Therapeutics, Inc. Recent Development
  • 13.2 AstraZeneca Plc
    • 13.2.1 AstraZeneca Plc Company Details
    • 13.2.2 AstraZeneca Plc Business Overview and Its Total Revenue
    • 13.2.3 AstraZeneca Plc Squamous Non-Small Cell Lung Cancer Therapeutics Introduction
    • 13.2.4 AstraZeneca Plc Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2015-2020)
    • 13.2.5 AstraZeneca Plc Recent Development
  • 13.3 AVEO Pharmaceuticals, Inc.
    • 13.3.1 AVEO Pharmaceuticals, Inc. Company Details
    • 13.3.2 AVEO Pharmaceuticals, Inc. Business Overview and Its Total Revenue
    • 13.3.3 AVEO Pharmaceuticals, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Introduction
    • 13.3.4 AVEO Pharmaceuticals, Inc. Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2015-2020)
    • 13.3.5 AVEO Pharmaceuticals, Inc. Recent Development
  • 13.4 Bayer AG
    • 13.4.1 Bayer AG Company Details
    • 13.4.2 Bayer AG Business Overview and Its Total Revenue
    • 13.4.3 Bayer AG Squamous Non-Small Cell Lung Cancer Therapeutics Introduction
    • 13.4.4 Bayer AG Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2015-2020)
    • 13.4.5 Bayer AG Recent Development
  • 13.5 BIND Therapeutics, Inc.
    • 13.5.1 BIND Therapeutics, Inc. Company Details
    • 13.5.2 BIND Therapeutics, Inc. Business Overview and Its Total Revenue
    • 13.5.3 BIND Therapeutics, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Introduction
    • 13.5.4 BIND Therapeutics, Inc. Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2015-2020)
    • 13.5.5 BIND Therapeutics, Inc. Recent Development
  • 13.6 Boehringer Ingelheim GmbH
    • 13.6.1 Boehringer Ingelheim GmbH Company Details
    • 13.6.2 Boehringer Ingelheim GmbH Business Overview and Its Total Revenue
    • 13.6.3 Boehringer Ingelheim GmbH Squamous Non-Small Cell Lung Cancer Therapeutics Introduction
    • 13.6.4 Boehringer Ingelheim GmbH Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2015-2020)
    • 13.6.5 Boehringer Ingelheim GmbH Recent Development
  • 13.7 Bristol-Myers Squibb Company
    • 13.7.1 Bristol-Myers Squibb Company Company Details
    • 13.7.2 Bristol-Myers Squibb Company Business Overview and Its Total Revenue
    • 13.7.3 Bristol-Myers Squibb Company Squamous Non-Small Cell Lung Cancer Therapeutics Introduction
    • 13.7.4 Bristol-Myers Squibb Company Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2015-2020)
    • 13.7.5 Bristol-Myers Squibb Company Recent Development
  • 13.8 Eli Lilly and Company
    • 13.8.1 Eli Lilly and Company Company Details
    • 13.8.2 Eli Lilly and Company Business Overview and Its Total Revenue
    • 13.8.3 Eli Lilly and Company Squamous Non-Small Cell Lung Cancer Therapeutics Introduction
    • 13.8.4 Eli Lilly and Company Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2015-2020)
    • 13.8.5 Eli Lilly and Company Recent Development
  • 13.9 F. Hoffmann-La Roche Ltd.
    • 13.9.1 F. Hoffmann-La Roche Ltd. Company Details
    • 13.9.2 F. Hoffmann-La Roche Ltd. Business Overview and Its Total Revenue
    • 13.9.3 F. Hoffmann-La Roche Ltd. Squamous Non-Small Cell Lung Cancer Therapeutics Introduction
    • 13.9.4 F. Hoffmann-La Roche Ltd. Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2015-2020)
    • 13.9.5 F. Hoffmann-La Roche Ltd. Recent Development
  • 13.10 Five Prime Therapeutics, Inc.
    • 13.10.1 Five Prime Therapeutics, Inc. Company Details
    • 13.10.2 Five Prime Therapeutics, Inc. Business Overview and Its Total Revenue
    • 13.10.3 Five Prime Therapeutics, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Introduction
    • 13.10.4 Five Prime Therapeutics, Inc. Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2015-2020)
    • 13.10.5 Five Prime Therapeutics, Inc. Recent Development
  • 13.11 Genentech, Inc.
    • 10.11.1 Genentech, Inc. Company Details
    • 10.11.2 Genentech, Inc. Business Overview and Its Total Revenue
    • 10.11.3 Genentech, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Introduction
    • 10.11.4 Genentech, Inc. Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2015-2020)
    • 10.11.5 Genentech, Inc. Recent Development
  • 13.12 Incyte Corporation
    • 10.12.1 Incyte Corporation Company Details
    • 10.12.2 Incyte Corporation Business Overview and Its Total Revenue
    • 10.12.3 Incyte Corporation Squamous Non-Small Cell Lung Cancer Therapeutics Introduction
    • 10.12.4 Incyte Corporation Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2015-2020)
    • 10.12.5 Incyte Corporation Recent Development
  • 13.13 Johnson & Johnson
    • 10.13.1 Johnson & Johnson Company Details
    • 10.13.2 Johnson & Johnson Business Overview and Its Total Revenue
    • 10.13.3 Johnson & Johnson Squamous Non-Small Cell Lung Cancer Therapeutics Introduction
    • 10.13.4 Johnson & Johnson Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2015-2020)
    • 10.13.5 Johnson & Johnson Recent Development
  • 13.14 MacroGenics, Inc.
    • 10.14.1 MacroGenics, Inc. Company Details
    • 10.14.2 MacroGenics, Inc. Business Overview and Its Total Revenue
    • 10.14.3 MacroGenics, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Introduction
    • 10.14.4 MacroGenics, Inc. Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2015-2020)
    • 10.14.5 MacroGenics, Inc. Recent Development
  • 13.15 Novartis AG
    • 10.15.1 Novartis AG Company Details
    • 10.15.2 Novartis AG Business Overview and Its Total Revenue
    • 10.15.3 Novartis AG Squamous Non-Small Cell Lung Cancer Therapeutics Introduction
    • 10.15.4 Novartis AG Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2015-2020)
    • 10.15.5 Novartis AG Recent Development
  • 13.16 Oncogenex Pharmaceuticals, Inc.
    • 10.16.1 Oncogenex Pharmaceuticals, Inc. Company Details
    • 10.16.2 Oncogenex Pharmaceuticals, Inc. Business Overview and Its Total Revenue
    • 10.16.3 Oncogenex Pharmaceuticals, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Introduction
    • 10.16.4 Oncogenex Pharmaceuticals, Inc. Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2015-2020)
    • 10.16.5 Oncogenex Pharmaceuticals, Inc. Recent Development
  • 13.17 PsiOxus Therapeutics Limited
    • 10.17.1 PsiOxus Therapeutics Limited Company Details
    • 10.17.2 PsiOxus Therapeutics Limited Business Overview and Its Total Revenue
    • 10.17.3 PsiOxus Therapeutics Limited Squamous Non-Small Cell Lung Cancer Therapeutics Introduction
    • 10.17.4 PsiOxus Therapeutics Limited Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2015-2020)
    • 10.17.5 PsiOxus Therapeutics Limited Recent Development

14 Analyst's Viewpoints/Conclusions

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    Summary:
    Get latest Market Research Reports on COVID-19 Impact on Global Squamous Non-Small Cell Lung Cancer Therapeutics. Industry analysis & Market Report on COVID-19 Impact on Global Squamous Non-Small Cell Lung Cancer Therapeutics is a syndicated market report, published as COVID-19 Impact on Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Size, Status and Forecast 2020-2026. It is complete Research Study and Industry Analysis of COVID-19 Impact on Global Squamous Non-Small Cell Lung Cancer Therapeutics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,900.00
    		$5,850.00
    		$7,800.00
    		3,120.00
    		4,680.00
    		6,240.00
    		3,642.60
    		5,463.90
    		7,285.20
    		615,966.00
    		923,949.00
    		1,231,932.00
    		325,377.00
    		488,065.50
    		650,754.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo